|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 80.10 EUR | +0.12% |
|
-0.06% | -1.48% |
| 07-10 | Polish air traffic control faces funding freeze over COVID vaccine ruling | RE |
| 07-08 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
Chart calendar BioNTech SE
Upcoming events on BioNTech SE
| 2026-08-03 | Earnings presentation | |
| 2026-08-04 | Earnings release - Q2 2026 | |
| 2026-11-02 | Earnings presentation | |
| 2026-11-03 | Earnings release - Q3 2026 |
Past events on BioNTech SE
| 2026-05-15 | Présentation aux Actionnaires / Analystes | 08:00 |
| 2026-05-14 | Annual General Meeting | |
| 2026-05-05 | Earnings presentation | 08:00 |
| 2026-05-05 | Earnings release - Q1 2026 | |
| 2026-03-10 | Earnings release - Q4 2025 | |
| 2026-03-10 | Earnings presentation | 08:00 |
| 2025-11-24 | Extraordinary General Meeting | |
| 2025-11-11 | Information meeting | 09:00 |
| 2025-11-03 | Earnings presentation | 08:00 |
| 2025-11-03 | Earnings release - Q3 2025 | |
| 2025-10-01 | Information meeting | 09:00 |
| 2025-08-04 | Earnings presentation | 08:00 |
| 2025-08-04 | Earnings release - Q2 2025 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 3 819 4 188 -8.8% | 2 751 2 648 3.91% | 2 870 2 653 8.19% | 2 168 | 2 231 | 2 505 |
|
EBITDA Million EUR | Released Forecast Spread | 874 986 -11.36% | -1 016 -1 232 17.53% | -1 022 -1 052 2.85% | -1 237 | -1 288 | -1 004 |
|
EBIT Million EUR | Released Forecast Spread | 690 866 -20.31% | -1 314 -1 468 10.49% | -1 405 -1 265 -11.02% | -1 468 | -1 518 | -1 266 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 1 186 1 270 -6.57% | -678 -838 19.11% | -1 051 -902 -16.54% | -1 088 | -1 199 | -1 020 |
|
Net income Million EUR | Released Forecast Spread | 930 1 070 -13.05% | -665 -807 17.55% | -1 136 -864 -31.52% | -1 042 | -1 165 | -978 |
|
EPS EUR | Released Forecast Spread | 3,83 4,45 -13.99% | -2,77 -3,30 15.97% | -4,70 -3,53 -33% | -4,39 | -4,56 | -4,00 |
| Announcement Date | 20/03/24 | 10/03/25 | 10/03/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 1 245 516 141.23% | 1 190 1 147 3.78% | 183 162 13.07% | 261 278 -6.04% | 1 519 1 006 51.03% | 907 763 18.95% | 118 155 -23.99% | 156 | 1 167 | 682 | 170 | 151 | 977 | 392 |
|
EBITDA Million EUR | Released Forecast Spread | 54,9 -169 132.49% | 314 130 141.54% | -491 -602 18.44% | -450 -696 35.3% | 77,3 283 -72.65% | -158 -111 -41.93% | -556 -660 15.73% | -725 | 71,6 | -293 | ||||
|
EBIT Million EUR | Released Forecast Spread | 10,5 -468 102.24% | 149 -67,8 319.31% | -534 -644 17.01% | -501 -524 4.46% | -46,9 -20,9 -124.55% | -323 -182 -77.35% | -678 -638 -6.14% | -638 | 103 | -291 | ||||
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 159 -309 151.38% | 301 77,5 288.65% | -445 -459 2.92% | -403 -83,1 -384.82% | 24,7 -67,2 136.77% | -227 -111 -104.24% | -568 -566 -0.31% | -525 | 105 | -124 | ||||
|
Net income Million EUR | Released Forecast Spread | 198 -358 155.4% | 260 57,6 350.52% | -416 -496 16.12% | -387 -231 -67.33% | -28,7 33,0 -186.93% | -305 -75,0 -306.77% | -532 -565 5.9% | -513 | 173 | -213 | ||||
|
EPS EUR | Released Forecast Spread | 0,81 -1,70 147.52% | 1,08 0,44 144.43% | -1,73 -2,27 23.93% | -1,60 -1,60 -0.23% | -0,12 0,32 -137.59% | -1,25 -0,26 -377.1% | -2,10 -2,32 9.66% | -2,08 | 0,99 | -1,27 | -1,86 | -1,97 | -0,23 | 0,81 |
| Announcement Date | 04/11/24 | 10/03/25 | 05/05/25 | 04/08/25 | 03/11/25 | 10/03/26 | 05/05/26 | - | - | - | - | - | - | - |
| 2026-07-23 |  | Earnings release - Q2 2026 | |
| 2026-07-23 | | Earnings presentation | 08:30 |
| 2026-07-23 | | Earnings release - Q2 2026 | |
| 2026-07-23 | | Earnings presentation | 16:30 |
| 2026-07-23 | | Earnings release - Q2 2026 | |
| 2026-07-27 | | Information meeting | 08:00 |
| 2026-07-28 | | Sales and Revenue Release - Q2 2026 | *E4DFANSWAPTOBAIJ22ORFMMWNCSDVOFTFBPAR |
| 2026-07-29 | | Extraordinary General Meeting | 20:30 |
| 2026-07-30 | | Earnings presentation | 08:00 |
| 2026-07-30 | | Earnings release - Q2 2026 |
Past sector events for BioNTech SE
| 2026-07-16 | | Information meeting | 08:00 |
| 2026-07-15 | | Extraordinary General Meeting | 20:01 |
| 2026-07-14 | | Information meeting | 17:30 |
| 2026-07-14 | | Présentation aux Actionnaires / Analystes | 00:00 |
| 2026-07-09 | | Significant Split/Dividend | 00:00 |
| 2026-07-09 | | Ex-dividend date - 1.49015 TWD | 00:00 |
| 2026-07-09 | | Earnings presentation | 02:00 |
| 2026-07-09 | | Information meeting | 08:30 |
| 2026-07-07 | | Earnings presentation | 02:30 |
| 2026-07-07 | | Earnings presentation | 00:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BNTX Stock
- 22UA Stock
- Calendar BioNTech SE
Select your edition
All financial news and data tailored to specific country editions
